The Regulatory Role of Toll-like Receptors After Ischemic Stroke: Neurosteroids As TLR Modulators with the Focus on TLR2/4

Overview

Journal Cell Mol Life Sci

Publisher Springer

Specialty Biology

Date 2018 Nov 1

PMID 30377701

Citations 35

Authors

Saeedeh Tajalli-Nezhad

Mohammad Karimian

Cordian Beyer

Mohammad Ali Atlasi

Abolfazl Azami Tameh

Affiliations

Soon will be listed here.

Abstract

Ischemic stroke is the most common cerebrovascular disease and considered as a worldwide leading cause of death. After cerebral ischemia, different pathophysiological processes including neuroinflammation, invasion and aggregation of inflammatory cells and up-regulation of cytokines occur simultaneously. In this respect, Toll-like receptors (TLRs) are the first identified important mediators for the activation of the innate immune system and are widely expressed in glial cells and neurons following brain trauma. TLRs are also able to interact with endogenous and exogenous molecules released during ischemia and can increase tissue damage. Particularly, TLR2 and TLR4 activate different downstream inflammatory signaling pathways. In addition, TLR signaling can alternatively play a role for endogenous neuroprotection. In this review, the gene and protein structures, common genetic polymorphisms of TLR2 and TLR4, TLR-related molecular pathways and their putative role after ischemic stroke are delineated. Furthermore, the relationship between neurosteroids and TLRs as neuroprotective mechanism is highlighted in the context of brain ischemia.

Citing Articles

Immune genes involved in synaptic plasticity during early postnatal brain development contribute to post-stroke damage in the aging male rat brain.

Pirscoveanu D, Olaru D, Hermann D, Doeppner T, Ghinea F, Popa-Wagner A Biogerontology. 2025; 26(2):60.

PMID: 39966204 DOI: 10.1007/s10522-025-10203-4.

Research on the innate immune response in transgenic mice following ischemic stroke.

Yuan C, Shentu Y, Ji Q Front Aging Neurosci. 2024; 16:1476913.

PMID: 39649720 PMC: 11621074. DOI: 10.3389/fnagi.2024.1476913.

DL-3-n-Butylphthalide Ameliorates Post-stroke Emotional Disorders by Suppressing Neuroinflammation and PANoptosis.

Cui Y, Hu Z, Wang L, Zhu B, Deng L, Zhang H Neurochem Res. 2024; 49(8):2215-2227.

PMID: 38834844 DOI: 10.1007/s11064-024-04171-3.

Stem cell therapy as a promising approach for ischemic stroke treatment.

Yaqubi S, Karimian M Curr Res Pharmacol Drug Discov. 2024; 6:100183.

PMID: 38831867 PMC: 11144755. DOI: 10.1016/j.crphar.2024.100183.

Neuroactive Steroids, Toll-like Receptors, and Neuroimmune Regulation: Insights into Their Impact on Neuropsychiatric Disorders.

Balan I, Boero G, Chery S, McFarland M, Lopez A, Morrow A Life (Basel). 2024; 14(5).

PMID: 38792602 PMC: 11122352. DOI: 10.3390/life14050582.

References

Sadeghi K, Wessner B, Laggner U, Ploder M, Tamandl D, Friedl J . Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol. 2006; 36(2):361-70. DOI: 10.1002/eji.200425995. View

Balden R, Selvamani A, Sohrabji F . Vitamin D deficiency exacerbates experimental stroke injury and dysregulates ischemia-induced inflammation in adult rats. Endocrinology. 2012; 153(5):2420-35. PMC: 3339639. DOI: 10.1210/en.2011-1783. View

Crocker S, Frausto R, Whitton J, Milner R . A novel method to establish microglia-free astrocyte cultures: comparison of matrix metalloproteinase expression profiles in pure cultures of astrocytes and microglia. Glia. 2008; 56(11):1187-98. PMC: 2776034. DOI: 10.1002/glia.20689. View

Schumacher M, Denier C, Oudinet J, Adams D, Guennoun R . Progesterone neuroprotection: The background of clinical trial failure. J Steroid Biochem Mol Biol. 2015; 160:53-66. DOI: 10.1016/j.jsbmb.2015.11.010. View

Lakhan S, Kirchgessner A, Hofer M . Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med. 2009; 7:97. PMC: 2780998. DOI: 10.1186/1479-5876-7-97. View

Kalueff A, Eremin K, Tuohimaa P . Mechanisms of neuroprotective action of vitamin D(3). Biochemistry (Mosc). 2004; 69(7):738-41. DOI: 10.1023/b:biry.0000040196.65686.2f. View

Cordeau Jr P, Lalancette-Hebert M, Weng Y, Kriz J . Estrogen receptors alpha mediates postischemic inflammation in chronically estrogen-deprived mice. Neurobiol Aging. 2016; 40:50-60. DOI: 10.1016/j.neurobiolaging.2016.01.002. View

Rusa R, Alkayed N, Crain B, Traystman R, Kimes A, London E . 17beta-estradiol reduces stroke injury in estrogen-deficient female animals. Stroke. 1999; 30(8):1665-70. DOI: 10.1161/01.str.30.8.1665. View

Hua F, Wang J, Ishrat T, Wei W, Atif F, Sayeed I . Genomic profile of Toll-like receptor pathways in traumatically brain-injured mice: effect of exogenous progesterone. J Neuroinflammation. 2011; 8:42. PMC: 3098165. DOI: 10.1186/1742-2094-8-42. View

10.

Hoffmann S, Beyer C, Zendedel A . Comparative analysis of gonadal steroid-mediated neuroprotection after transient focal ischemia in rats: route of application and substrate composition. J Mol Neurosci. 2014; 56(1):12-6. DOI: 10.1007/s12031-014-0462-9. View

11.

Zhou L, Zheng D, Wang S, Zhu J, Jia Y, Sun D . Genetic association of Toll-like receptor 4 gene and coronary artery disease in a Chinese Han population. Springerplus. 2016; 5(1):1533. PMC: 5019996. DOI: 10.1186/s40064-016-3177-2. View

12.

Wang Y, Lin S, Yang Q . Toll-like receptors in cerebral ischemic inflammatory injury. J Neuroinflammation. 2011; 8:134. PMC: 3198933. DOI: 10.1186/1742-2094-8-134. View

13.

Ghisletti S, Meda C, Maggi A, Vegeto E . 17beta-estradiol inhibits inflammatory gene expression by controlling NF-kappaB intracellular localization. Mol Cell Biol. 2005; 25(8):2957-68. PMC: 1069609. DOI: 10.1128/MCB.25.8.2957-2968.2005. View

14.

Kawagoe T, Sato S, Matsushita K, Kato H, Matsui K, Kumagai Y . Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2. Nat Immunol. 2008; 9(6):684-91. DOI: 10.1038/ni.1606. View

15.

BAULIEU E, Schumacher M . Progesterone as a neuroactive neurosteroid, with special reference to the effect of progesterone on myelination. Steroids. 2000; 65(10-11):605-12. DOI: 10.1016/s0039-128x(00)00173-2. View

16.

Zhang Q, Raz L, Wang R, Han D, de Sevilla L, Yang F . Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha-mediated inhibition of NADPH oxidase activation. J Neurosci. 2009; 29(44):13823-36. PMC: 2807671. DOI: 10.1523/JNEUROSCI.3574-09.2009. View

17.

Caso J, Pradillo J, Hurtado O, Leza J, Moro M, Lizasoain I . Toll-like receptor 4 is involved in subacute stress-induced neuroinflammation and in the worsening of experimental stroke. Stroke. 2008; 39(4):1314-20. DOI: 10.1161/STROKEAHA.107.498212. View

18.

De Baets G, Van Durme J, Reumers J, Maurer-Stroh S, Vanhee P, Dopazo J . SNPeffect 4.0: on-line prediction of molecular and structural effects of protein-coding variants. Nucleic Acids Res. 2011; 40(Database issue):D935-9. PMC: 3245173. DOI: 10.1093/nar/gkr996. View

19.

Ishrat T, Sayeed I, Atif F, Hua F, Stein D . Progesterone and allopregnanolone attenuate blood-brain barrier dysfunction following permanent focal ischemia by regulating the expression of matrix metalloproteinases. Exp Neurol. 2010; 226(1):183-90. PMC: 2963070. DOI: 10.1016/j.expneurol.2010.08.023. View

20.

Strom J, Theodorsson A, Theodorsson E . Dose-related neuroprotective versus neurodamaging effects of estrogens in rat cerebral ischemia: a systematic analysis. J Cereb Blood Flow Metab. 2009; 29(8):1359-72. DOI: 10.1038/jcbfm.2009.66. View